2D echocardiography is limited for identifying chemotherapy-related cardiotoxicity. This study compared standard echo, 2D, and 3D speckle tracking echocardiography (STE) for detection of subclinical anthracycline (ANT) cardiotoxicity in breast cancer patients.
2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility / Santoro, Ciro; Arpino, Grazia; Esposito, Roberta; Lembo, Maria; Paciolla, Immacolata; Cardalesi, Cinzia; DE SIMONE, Giovanni; Trimarco, Bruno; DE PLACIDO, Sabino; Galderisi, Maurizio. - In: EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING. - ISSN 2047-2404. - (2017). [10.1093/ehjci/jex033]
2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility
SANTORO, CIRO;ARPINO, GRAZIA;ESPOSITO, roberta;LEMBO, MARIA;PACIOLLA, IMMACOLATA;CARDALESI, CINZIA;DE SIMONE, GIOVANNI;TRIMARCO, BRUNO;DE PLACIDO, SABINO;GALDERISI, MAURIZIO
2017
Abstract
2D echocardiography is limited for identifying chemotherapy-related cardiotoxicity. This study compared standard echo, 2D, and 3D speckle tracking echocardiography (STE) for detection of subclinical anthracycline (ANT) cardiotoxicity in breast cancer patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
